Diadema Partners LP Insmed Inc Call Options Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.52 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.19 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.08 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$1.06 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$595 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $11.3B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...